Vishal Shah

Vishal Shah

Mayo Clinic - Rochester / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5716399
Mayo Clinic College of Medicine and Science
person_outline Vishal Shah's MOST POPULAR ARTICLES
1-) Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer: A real-world report from the cancer therapy using checkpoint inhibitors in people …T El Zarif, AH Nassar, E Adib, BG Fitzgerald, J Huang, TH Mouhieddine, ...Journal of Clinical Oncology 41 (21), 3712-3723, 2023202023
2-) Contradictions in contraindications for drug-drug interactionsVS Shah, RJ Weber, MC NahataAnnals of Pharmacotherapy 45 (3), 409-411, 2011192011
3-) Abemaciclib: the first FDA-approved CDK4/6 inhibitor for the adjuvant treatment of HR+ HER2− early breast cancerF Raheem, H Ofori, L Simpson, V ShahAnnals of Pharmacotherapy 56 (11), 1258-1266, 2022102022
4-) Single dose versus multiple doses of rituximab for preemptive therapy of Epstein–Barr virus reactivation after hematopoietic cell transplantationT Jain, HE Kosiorek, TE Grys, ST Kung, VS Shah, JA Betcher, JL Slack, ...Leukemia & Lymphoma 60 (1), 110-117, 2019102019
5-) Amivantamab-vmjw: a novel treatment for patients with NSCLC harboring EGFR Exon 20 insertion mutation after progression on platinum-based chemotherapyV Shah, A McNatty, L Simpson, H Ofori, F RaheemBiomedicines 11 (3), 950, 2023